You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RWS

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast

Active, not recruiting
  • To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast Cancer After 5 Years
  • OFS continues to use group after 5 years
  • Immunohistochemical detection of HR status
  • Wuhan, Hubei, China
    Wu Xinhong
Sep 17, 2023

da Vinci SP Surgical System for Single-Port Colorectal

Recruiting
  • Single-Port Colorectal Surgeries
  • procedure
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 15, 2023

HPV Vaccination on HPV Infection and Cervical Related Disease

Not yet recruiting
  • HPV Infection
  • Cervical Disease
  • Questionnaire Survey and Cervical Cancer Screening
  • (no location specified)
Apr 24, 2022

da Vinci SP Surgical System for Single-Port Gynecological

Recruiting
  • Gynecological Surgeries
  • da Vinci SP Surgical System
  • Shanghai, Shanghai, China
    Shanghai JiaoTong University School of Medicine affliated Ruijin
Oct 8, 2023

Localized T1-T2 Prostate Cancer Trial in Qionghai (SpaceOAR Treatment)

Recruiting
  • Localized T1-T2 Prostate Cancer
  • SpaceOAR Treatment
  • Qionghai, Hainan, China
    Boao First Life Care Center-Hospital
Jan 17, 2023

A RWS of the FARAPULSE in A Chinese Population With PAF

Not yet recruiting
  • Paroxysmal Atrial Fibrillation
  • FARAPULSE Pulsed Field Ablation System
  • (no location specified)
Aug 7, 2022

Preliminary Safety and Performance of Rezum System in BPH

Completed
Has Results
  • Benign Prostatic Hyperplasia (BPH)
  • Rezūm System
  • Boao, Hainan, China
    Boao Yiling Life Care Center
Feb 17, 2022

RWS of Inetetamab HER2 Positive Advanced Breast Cancer

Not yet recruiting
  • HER2-positive Advanced Breast Cancer
  • (no location specified)
Jul 14, 2021

Zoladex® 10.8 BC RWS

Recruiting
  • Breast Cancer
    • Beijing, China
    • +19 more
    Jul 12, 2022

    A Multi-center RWS of Perampanel asadd-on Treatment for

    Active, not recruiting
    • Epilepsy
    • Beijing, Beijing, China
    • +4 more
    Mar 10, 2022

    Effectiveness and Safety of Perampanel asadd-on Treatment for

    Active, not recruiting
    • Epilepsy
    • Beijing, Beijing, China
    • +4 more
    Feb 24, 2022

    Cardiac Ablation for PSVT Using ST Catheter

    Completed
    • AVRT, AVNRT
    • THERMOCOOL SMARTTOUCH® Diagnostic/Ablation Deflectable Tip Catheter
    • Beijing, Beijing, China
    • +2 more
    Feb 22, 2022

    (RWS) of Lanreotide Autogel for Treatment of Acromegaly in China

    Recruiting
    • Acromegaly
      • Beijing, China
      • +11 more
      Jul 13, 2022

      Breast Cancer Trial in Tianjin

      Recruiting
      • Breast Cancer
        • Tianjin, China
          TianJin Medical University Cancer Institute and Hospital
        Jul 18, 2021

        ST-Segment Elevation Myocardial Infarction, Multivessel Coronary Artery Disease, Percutaneous Coronary Intervention Trial (FAST

        Not yet recruiting
        • ST-Segment Elevation Myocardial Infarction
        • +2 more
        • FAST Technique
        • Angiography
        • (no location specified)
        Jan 1, 2023

        Natural History of Coronary Atherosclerosis

        Not yet recruiting
        • Coronary Artery Disease Progression
        • +3 more
          • (no location specified)
          Sep 13, 2023

          Esophageal Cancer Trial in Beijing (3DCRT)

          Recruiting
          • Esophageal Cancer
          • 3DCRT
          • Beijing, Beijing, China
            Department of Radiation Oncology, National Cancer Center/Nationa
          Sep 13, 2022

          Eosinophilic Esophagitis Trial in Australia, Spain, United States (APT-1011, Placebo oral tablet)

          Completed
          • Eosinophilic Esophagitis
          • Anniston, Alabama
          • +54 more
          Nov 9, 2022

          Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

          Not yet recruiting
          • NSCLC
            • Changsha, Hunan, China
              Hunan Cancer Hospital
            Aug 6, 2023

            Extensive Stage Small Cell Lung Cancer

            Not yet recruiting
            • Extensive-stage Small-cell Lung Cancer
              • Changsha, Hunan, China
                Hunan Cancer hospital
              Aug 6, 2023

              NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT

              Recruiting
              • Advanced Solid Tumors or Lymphomas
              • Changsha, Hunan, China
                Hunan Provincal Tumor Hospital
              Oct 5, 2023

              Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung

              Recruiting
              • Non-small Cell Lung Cancer (NSCLC)
              • Jinan, Shandong, China
                Shandong Cancer Hospital and Institute
              Aug 8, 2023

              Advanced Lung Squamous Cell Carcinoma

              Not yet recruiting
              • Advanced Lung Squamous Cell Carcinoma
              • No treatment is included in this study
              • Changsha, Hunan, China
                Yongchang Zhang
              Aug 11, 2023

              Treatment of Gynecological Malignant Tumors in China : A Real

              Active, not recruiting
              • Gynecologic Cancer
              • +3 more
                • Wuhan, Hubei, China
                  Tongji Hospital
                Oct 6, 2021

                Central Nervous System Metastatic EGFR Mutation Positive NSCLC

                Not yet recruiting
                • NSCLC
                  • Changsha, Hunan, China
                    Hunan Cancer hospital
                  Aug 6, 2023